Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03878589 · ClinicalTrials.gov registry record · Phase 2
Understanding Cognition, Oxytocin & Pain in Elders
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 83
- Enrollment target
NCT03878589 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 83 participants.
The verdict
NCT03878589, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 83 participants
- Enrollment target
Study Summary
Osteoarthritis (OA) represents a significant cause of disability worldwide and the knee is the most commonly affected joint. Oxytocin (OT) is a mediator of endogenous analgesia in animal and human studies. This proposal will test the efficacy and safety of self-administered intranasal OT over 4-weeks in older individuals relative to placebo (P) evaluating its effects on pain and function in aging and testing potential underlying neurobiological mechanisms.
Interventions
- DRUG Placebo (P)
- DRUG Oxytocin (OT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2019-08-06 |
| Est. Completion | 2024-12-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03878589
The ClinicalTrials.gov registry entry for NCT03878589 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo (P) is the first listed.
NCT03878589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03878589 about?
NCT03878589 is a clinical study titled "Understanding Cognition, Oxytocin & Pain in Elders". Osteoarthritis (OA) represents a significant cause of disability worldwide and the knee is the most commonly affected joint. Oxytocin (OT) is a mediator of endogenous analgesia in animal and human studies. This proposal will test the efficacy and safety of self-administered intranasal OT over 4-week...
What is the current status of trial NCT03878589?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 83 participants. The study started on 2019-08-06. Estimated completion is 2024-12-19.
What interventions are being tested in trial NCT03878589?
The interventions under investigation include: Placebo (P) (DRUG), Oxytocin (OT) (DRUG).
Who is sponsoring clinical trial NCT03878589?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.